Clinicopathological Predictors of Poor Survival and Recurrence After Curative Resection in Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis
- 8 June 2014
- journal article
- Published by Springer Science and Business Media LLC in Pathology and Oncology Research
- Vol. 21 (1), 131-138
- https://doi.org/10.1007/s12253-014-9798-2
Abstract
Many factors associated with long-term outcome in hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) were previously identified. However, those in HCC without PVTT have not been elucidated. This study was designed to define the risk factors of poor post-surgical survival and recurrence in this subgroup of HCC. Medical records and follow-up data of consecutive 152 patients with PVTT-absent HCC underwent curative resection were reviewed. The impacts of clinical and pathological variables on patient survival and recurrence were evaluated by univariate and multivariate analyses. It was shown that Edmondson-Steiner grade, TNM stage, microvascular invasion (MVI), satellite nodule, serum AFP level, tumor size and number were significant for tumor-specific and/or tumor-free survival in univariate analysis. Among them, Edmondson-Steiner grade and TNM stage were of independent significances for both, whereas satellite nodule independently predicted tumor-free survival. In Chi-square test, Edmondson-Steiner grade, TNM stage and MVI were significantly related to overall as well as early recurrence. Stepwise logistic regression identified Edmondson-Steiner grade as the single independent predictor of both. To be summarized, variables that are associated with poor prognosis and recurrence in HCC without PVTT are all tumor-related ones. Of these, differentiation degree might be of particular importance.Keywords
This publication has 42 references indexed in Scilit:
- Evaluation of the new AJCC staging system for resectable hepatocellular carcinomaWorld Journal of Surgical Oncology, 2011
- Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinomaBritish Journal of Cancer, 2010
- An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombusZeitschrift für Krebsforschung und Klinische Onkologie, 2010
- A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular CarcinomaGastroenterology, 2009
- Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studiesLiver International, 2009
- Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinomaInternational Journal of Clinical Oncology, 2007
- Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinomaExperimental & Molecular Medicine, 2007
- Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Clinical Characteristics, Prognosis, and Patient Survival AnalysisDigestive Diseases and Sciences, 2007
- The Brisbane 2000 Terminology of Liver Anatomy and Resections. HPB 2000; 2:333‐39HPB, 2002
- Angioechographic evaluation of tumor thrombi and the effect of transcatheter arterial embolization in patients with hepatocellular carcinomaThe Esophagus, 2002